Navigation Links
New Strategy Eyed for AIDS Treatment

Discovery of HIV hiding places may pave way for novel therapies

MONDAY, June 22 (HealthDay News) -- A radical new therapy could improve treatment of people with HIV-AIDS by destroying the viruses circulating in the body as well as those hiding in immune system cells, according to a new study.

A team of American and Canadian researchers have high hopes for a combination of targeted chemotherapy and what's known as highly active anti-retroviral (HAART) treatments.

When HIV viruses hide in immune cells, the researchers explained, existing HAART treatments can't reach them. But the study identified where HIV hides in immune cells and the "stealth" mechanisms that enable the virus to elude existing treatments. This finding could lead to new therapies that are different than current treatments, they said.

"Our results argue in favor of a strategy similar to the one used against leukemia, which is targeted chemotherapy, associated with a targeted immune treatment," study co-leader Dr. Rafick-Pierre Sekaly, a professor at the University of Montreal and scientific director of the Vaccine and Gene Therapy Institute of Florida, said in a university news release. "This would make it possible to destroy the cells containing a virus while giving the immune system time to regenerate with healthy cells."

Another co-leader, Dr. Jean-Pierre Routy, an infection and immunity researcher at the Research Institute of the McGill University Health Centre in Montreal, explained the importance of the finding.

"For the first time, this study proves that the HIV reservoirs are not due to a lack of potency of the antiretroviral drugs but to the virus hiding inside two different types of long-life CD4 memory immune cells," Routy said in the news release. "There are several types of HIV reservoirs, each necessitating a different treatment to eliminate them."

The researchers acknowledged, however, that it will take many more years of work before the finding might lead to new treatments for people with HIV-AIDS.

The study appears in the journal Nature Medicine.

More information

The U.S. National Institute of Allergy and Infectious Diseases has more about HIV-AIDS treatment.

-- Robert Preidt

SOURCE: University of Montreal, news release, June 21, 2009

Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. AMDL CEO Featured in CEOCFO Magazine; Details Progress on DR-70 International Commercialization Strategy & Confidence in FY2009 Financial Forecast
2. DURECT Appoints Dr. Joseph Stauffer as Chief Medical Officer and Executive Vice President, Corporate Strategy
3. NIAID media availability: New strategy proposed for designing antibody-based HIV vaccine
4. XELR8 Holdings, Inc. Hires Vice President of Strategy and Network Development
5. Alere Executives Present National Health Improvement Strategy to Congressional and Industry Leaders
6. Diplomat Specialty Pharmacy Promotes Rinku A. Patel, PharmD to Vice President, Pharmacy Strategy
7. MDS Announces Strategy to Focus MDS Pharma Services on Early Stage Operations - Discovery Through Phase IIa
8. Sisters of Charity Health System Appoints Orlando L. Alvarez Jr. to Head Physician Strategy and Business Development
9. Cutler to Direct Debt Management Product Strategy at Ontario Systems
10. American College of Physicians Chooses iPublishCentral to Launch its e-Book Strategy
11. American College of Physicians Chooses iPublishCentral to Launch its e-Book Strategy
Post Your Comments:
Related Image:
 New Strategy Eyed for AIDS Treatment
(Date:11/29/2015)... , ... November 29, 2015 , ... ... and unique analog distortion effect tool designed specially for Final Cut Pro X. ... create limiltess looks with the easy-to-use modification controls. Destoying and creating chaotic distortion ...
(Date:11/28/2015)... ... November 28, 2015 , ... Safe storage for contraceptive devices may ... one from Lakewood, New Jersey and the other from Bradley Beach, New Jersey, there ... save the expense of having to replace NuvaRings more often than necessary. As such, ...
(Date:11/27/2015)... ... , ... There is only one major question facing all law firms in ... question has not been an easy question to answer. Especially when the senior partners ... workforce don’t share the same discipline around working long hours. , In addition ...
(Date:11/27/2015)... ... 27, 2015 , ... The rapid speed at which Americans ... more care is needed, especially with Alzheimer’s, dementia and other cognitive conditions becoming ... The forgotten part of this equation: 80 percent of medical care occurs in ...
(Date:11/27/2015)... ... November 27, 2015 , ... Lizzie’s Lice Pickers just announced ... offering customers 10% off of their purchase of lice treatment product. In addition, customers ... According to a company spokesperson. “Finding lice is a sure way to ruin the ...
Breaking Medicine News(10 mins):
(Date:11/29/2015)... 2015   National Decision Support Company (NDSC) continues ... including notable statewide implementations. As a result, ordering ... Select, more than 1 million times per month—all ... Select provides real-time feedback on the most appropriate ... been implemented at over 100 healthcare systems nationally, ...
(Date:11/27/2015)... 2015  Lannett Company, Inc. (NYSE: LCI ... acquisition of Kremers Urban Pharmaceuticals Inc. (KU), the ... company UCB S.A. (Euronext: UCB). ... KU from UCB for total consideration of approximately ... customary working capital adjustment, a deduction of certain ...
(Date:11/26/2015)... , Países Bajos, November 26, 2015 ... la terapia fotodinámica de Bremachlorin para el cáncer avanzado. ... la inmunoterapia con la terapia fotodinámica de Bremachlorin para ... Un nuevo enfoque combina la inmunoterapia con la terapia ... Clinical Cancer Research . --> ...
Breaking Medicine Technology: